Viz.ai gets FDA De Novo approval for AI-enabled heart disease detection
Viz.ai gets FDA De Novo approval for AI-enabled heart disease detection Andrea Fox
The U.S. Food and Drug
Podcast - Insights on the FTC's Approach to Digital Health Companies
Podcast - Insights on the FTC's Approach to Digital Health Companies unknown
In this episode of "Counsel
Swissmedic wird Teil der EU-Medikamenten-Initiative
Swissmedic wird Teil der EU-Medikamenten-Initiative info@medinside.ch (ab )
Wie Swissmedic in einer Mitteilung schreibt, wird sie Teil der Medikamenten-Initiative
Diese Spitäler dürfen komplizierte Bauchoperationen machen
Diese Spitäler dürfen komplizierte Bauchoperationen machen info@medinside.ch (Esther Diener)
Ab 2024 dürfen in der Schweiz nur noch 15
Kantonsspital will GDK-Entscheid juristisch anfechten
Kantonsspital will GDK-Entscheid juristisch anfechten info@medinside.ch (Claude Chatelain)
Bloss 15 Spitäler dürfen ab 2024 bei Darmkrebs den Enddarm
FDA Updates for the Week of July 17, 2023
FDA Updates for the Week of July 17, 2023 unknown
FDA Approves Novel Therapy for Newly Diagnosed AML.
The FDA
FDA Grants Clearance for UltraSight's AI-Powered Cardiac Ultrasound Technology
FDA Grants Clearance for UltraSight's AI-Powered Cardiac Ultrasound Technology unknown Today, UltraSight, a digital health pioneer transforming cardiac
Value in Health Care Act of 2023 Introduced to Congress to Reinforce Value-Based Care
Value in Health Care Act of 2023 Introduced to Congress to Reinforce Value-Based Care unknown
Seventeen of the nation’s
Finland banks on health tech to keep seniors cared for at home longer
Finland banks on health tech to keep seniors cared for at home longer unknown
At Kustaankartono Senior Centre, the largest
FDA Updates for the Week of July 31, 2023
FDA Approves Lonsurf Combination for Metastatic Colorectal Cancer.
The FDA has approved Lonsurf (trifluridine and tipiracil) as a single agent